AZN ▲ +0.4% - AstraZeneca PLC
$AZN AstraZeneca Receives Two U.S. FDA Approvals, Including Expanded Use of Imfinzi and a New Treatment for a Rare Disease
16-NOV-2026 05:18 AM ET
Share this post
More filings for $AZN
AZN ▲ +0.3% - AstraZeneca PLCNov 13, 2026AZN ▲ +0.2% - AstraZeneca PLCNov 13, 2026AZN ▲ +2.9% - AstraZeneca PLCNov 4, 2026AZN ▲ +4.0% - AstraZeneca PLCOct 30, 2026AZN ▼ -0.6% - AstraZeneca PLCOct 24, 2026AZN ▼ -0.7% - AstraZeneca PLCOct 5, 2026
View full $AZN filing history →💬 Comments
Loading comments…
Leave a comment
